Qiagen (QGEN) Asset Writedowns and Impairment (2014 - 2026)
Qiagen (QGEN) posted Asset Writedowns and Impairment of $15.2 million for Q1 2026, down 23.54% sequentially from $19.9 million in Q4 2025, and up 499.84% YoY from $2.5 million in Q1 2025.
Qiagen (QGEN) Asset Writedowns and Impairment (2014 - 2026) Analysis & Trends
Qiagen has reported Asset Writedowns and Impairment for 10 years, with the latest figure at $15.2 million in Q1 2026.
- Quarterly Asset Writedowns and Impairment rose 499.84% year-over-year to $15.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.1 million (down 65.67% YoY) and the FY2025 annual result came in at $22.4 million, down 88.97% from the prior year.
- Asset Writedowns and Impairment fell to $15.2 million in Q1 2026 per QGEN's latest filing, from $19.9 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $93.5 million in Q4 2024 and troughed at -$9.6 million in Q4 2022.
- A 4-year average of $18.8 million and a median of $10.7 million in 2024 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2025 and 2026: Asset Writedowns and Impairment slumped 78.71% in 2025, then surged 499.84% in 2026.
- Over 4 years, Asset Writedowns and Impairment stood at -$9.6 million in 2022, then soared by 1075.48% to $93.5 million in 2024, then plunged by 78.71% to $19.9 million in 2025, then slipped by 23.54% to $15.2 million in 2026.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $15.2 million, $19.9 million, and $2.5 million for Q1 2026, Q4 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Qiagen | 8.65 Bn | 8.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.22 Mn |
| Mar 31, 2026 | 15.22 Mn |
| Dec 31, 2025 | 19.90 Mn |
| Dec 31, 2025 | 19.90 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Dec 31, 2024 | 93.50 Mn |
| Dec 31, 2024 | 93.50 Mn |
| Sep 30, 2024 | 6.26 Mn |
| Sep 30, 2024 | 6.26 Mn |
| Dec 31, 2022 | -9.59 Mn |
| Dec 31, 2022 | -9.59 Mn |
| Sep 30, 2022 | 22.40 Mn |
| Sep 30, 2022 | 22.40 Mn |
| Mar 31, 2022 | 153,000.00 |
| Mar 31, 2022 | 153,000.00 |
| Dec 31, 2020 | 398,000.00 |
| Dec 31, 2020 | 398,000.00 |
| Jun 30, 2020 | 75,000.00 |
| Jun 30, 2020 | 75,000.00 |